Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Evaporative Heavy Liquids for Retinal Tamponade
Author Affiliations & Notes
  • Avnish Deobhakta
    New York Eye and Ear Infirmary of Mount Sinai Ophthalmology, New York, New York, United States
  • Richard B Rosen
    New York Eye and Ear Infirmary of Mount Sinai Ophthalmology, New York, New York, United States
  • Paul Lee
    New York Eye and Ear Infirmary of Mount Sinai Ophthalmology, New York, New York, United States
    Ophthalmology, James J. Peters Department of Veterans Affairs Medical Center, Bronx, New York, United States
  • Harriet Lloyd
    New York Eye and Ear Infirmary of Mount Sinai Ophthalmology, New York, New York, United States
  • Footnotes
    Commercial Relationships   Avnish Deobhakta Alimera Sciences, Inc., Code C (Consultant/Contractor), Avant Sciences, Inc., Code O (Owner), Avant Sciences, Inc., Code P (Patent); Richard Rosen Visionix (OptoVue), Boehringer-Ingelheim, Regeneron, CellView, Lumithera, Code C (Consultant/Contractor), Visionix (OptoVue), Ocusciences, Opticology, Topcon, Canon, Code F (Financial Support), Visionix (OptoVue), Guardion, Opticology, CellView, Code I (Personal Financial Interest), Avant Sciences, Inc., Code O (Owner), Visionix (OptoVue), Code P (Patent); Paul Lee Avant Sciences, Inc., Code O (Owner), Avant Sciences, Inc., Code P (Patent); Harriet Lloyd Avant Sciences, Inc., Code O (Owner)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 887. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Avnish Deobhakta, Richard B Rosen, Paul Lee, Harriet Lloyd; Evaporative Heavy Liquids for Retinal Tamponade. Invest. Ophthalmol. Vis. Sci. 2024;65(7):887.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To identify a set of non-toxic optically clear heavy liquids for retinal tamponade that can evaporate within the vitreous cavity under normal biological conditions.

Methods : Four eyes of four non-vitrectomized 9 week old Dutch Belted Rabbits were injected with 8 microliters of a novel heavy liquid EOD-2, with an equivalent amount of balanced salt solution (BSS) in the other four eyes as a control. Clinical exams, fundus photos, and intraocular pressures were obtained at baseline and days 3, 8, 18, and 30.

Results : EOD-2 was noted in the posterior pole on post-injection Day 1 in all 4 treated eyes. By Day 3, EOD-2 had evaporated in all eyes, leaving a relatively large superior gas bubble near the lens. By Day 8, this gas bubble had completely disappeared, and did not return on Day 18 and Day 30 (Figure 1). Outside of the existence of EOD-2, clinical examinations and fundus photography showed no significant differences between the test eyes and those treated with BSS. Intraocular pressure readings did not differ with statistical significance relative to the eyes treated with BSS at baseline, Day 3, Day 8, Day 18, and Day 30, and showed a similar trend in fluctuations throughout the study (Figure 2).

Conclusions : EOD-2 is part of a suite of novel heavy liquid retinal tamponades that appear to be non-toxic and can evaporate and reabsorb under normal biological conditions. Much like previously reported EOD-1, EOD-2 could be used intraoperatively akin to other heavy liquid tamponades without the known drawbacks of heavy liquid retention within the eye, albeit with a faster evaporation rate from the eye.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×